Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


Pre-Filled Syringes Americas

31 Mar 2014 - 01 Apr 2014 - Iselin, NJ, USA



Bookmark and Share


Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

The importance of pre-filled syringes and injection devices have never been more pertinent, especially in the US. The challenges of finding a delivery method with patient centric design that avoids leaching, requires swift and decisive decisions early in the development process to avoid unnecessary costs and delays in development.

The SMi Group announces its Pre-Filled Syringes America Conference will be taking place in Iselin, New Jersey, USA, on the 31st March – 1st April 2014, where solutions to these challenges will be offered by many of the leading names in pharmaceuticals and medical device technologies.

Event’s website: http://www.smi-online.co.uk/2014pfs-usa30.asp  

Registration is now open. Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Benefits of attending:

• 3 days of presentations, panel discussions and an interactive workshop. Return to your business with the information and contacts to make the

right decisions for your products

• Focus sessions on biologics, manufacturing, polymers and extractables and leachables

• 20+ expert speakers from throughout the PFS and device ecosystem

• 85+ key decision makers, influencers and innovation drivers attending from the most relevant and sought after organisations in pre-filled syringes

• Network with delegates from the leading Biotechnology and Pharmaceutical businesses globally during the series of networking breaks, lunches and networking evenings designed to help conversation flow

• Hands on exhibition to help you evaluate the leading solutions in the marketplace and meet the thought leaders who developed them 

Key speakers include:

• Scott Brown, Device Development Lead, Merck 

• Alexei Goraltchouk, Senior Manager, Operations, Regeneron

• Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories

• Steven Projan, SVP, MedImmune*

• Martin Dearden, Chief Corporate Microbiologist, UCB

• Thomas Osterberg, Senior Manager, Biologics, Pfizer Inc

• Greg Sacha, Senior Research Scientist, Baxter

• Christian Siegmund, Head of Prefilled Syringes and Liquid Vials, Roche

• Ravi S. Harapanhalli, Vice President, ParExel, and Former FDA Senior Executive

and many others.

For further information please contact Fateja Begum on +44 (0)20 7827 6184 or email: pharma@smiconferences.co.uk




Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!